Advanced search
Publication Cover
mAbs Volume 10, 2018 - Issue 5
Submit an article Journal homepage
2,877
Views
7
CrossRef citations to date
0
Altmetric
Reports

Delivery of ALX-0171 by inhalation greatly reduces respiratory syncytial virus disease in newborn lambs

Alejandro Larios MoraCollege of Veterinary Medicine, Department of Veterinary Pathology, Iowa State University, Ames, IA, USAView further author information
,
Laurent DetalleAblynx NV, Zwijnaarde, BelgiumCorrespondence[email protected]
View further author information
,
Jack M. GallupCollege of Veterinary Medicine, Department of Veterinary Pathology, Iowa State University, Ames, IA, USAORCID Iconhttp://orcid.org/0000-0003-4675-0731View further author information
ORCID Icon,
Albert Van GeelenCollege of Veterinary Medicine, Department of Veterinary Pathology, Iowa State University, Ames, IA, USAView further author information
,
Thomas StohrAblynx NV, Zwijnaarde, BelgiumView further author information
,
Linde DuprezAblynx NV, Zwijnaarde, BelgiumView further author information
&
Mark R. AckermannCollege of Veterinary Medicine, Department of Veterinary Pathology, Iowa State University, Ames, IA, USAORCID Iconhttp://orcid.org/0000-0002-3522-5395View further author information
ORCID Icon show all
Pages 778-795 | Received 22 Dec 2017, Accepted 25 Apr 2018, Published online: 07 May 2018

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Benjamín Diethelm-Varela, Jorge A Soto, Claudia A Riedel, Susan M Bueno & Alexis M Kalergis. (2023) New Developments and Challenges in Antibody-Based Therapies for the Respiratory Syncytial Virus. Infection and Drug Resistance 16, pages 2061-2074.
Read now
Jorge A. Soto, Ricardo A. Loaiza, Sebastián Echeverría, Robinson A. Ramírez & Alexis M. Kalergis. (2023) Current and emerging pharmacological treatments for respiratory syncytial virus infection in high-risk infants. Expert Opinion on Pharmacotherapy 24:10, pages 1143-1158.
Read now
Thomas J. Esparza, Yaozong Chen, Negin P. Martin, Helle Bielefeldt-Ohmann, Richard A. Bowen, William D. Tolbert, Marzena Pazgier & David L. Brody. (2022) Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological, and pathological disease in a Syrian hamster model of COVID-19. mAbs 14:1.
Read now
J.A Soto, N.M.S Galvez, D.B Rivera, F.E Díaz, C.A Riedel, S.M Bueno & A.M Kalergis. (2022) From animal studies into clinical trials: the relevance of animal models to develop vaccines and therapies to reduce disease severity and prevent hRSV infection. Expert Opinion on Drug Discovery 17:11, pages 1237-1259.
Read now
Maria Gabriella Matera, Luigino Calzetta, Josuel Ora, Paola Rogliani & Mario Cazzola. (2021) Pharmacokinetic/pharmacodynamic approaches to drug delivery design for inhalation drugs. Expert Opinion on Drug Delivery 18:7, pages 891-906.
Read now
Seyhan Boyoglu-Barnum & Ralph A. Tripp. (2020) Up-to-date role of biologics in the management of respiratory syncytial virus. Expert Opinion on Biological Therapy 20:9, pages 1073-1082.
Read now
Harrison C. Bergeron & Ralph A. Tripp. (2020) Emerging small and large molecule therapeutics for respiratory syncytial virus. Expert Opinion on Investigational Drugs 29:3, pages 285-294.
Read now

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.